CYDX (Cyduct Diagnostics) FCF Margin %: 0.00% (As of . 20)


What is Cyduct Diagnostics FCF Margin %?

Cyduct Diagnostics CYDX +4.22% FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cyduct Diagnostics's Free Cash Flow for the three months ended in . 20 was $0.00 Mil. Cyduct Diagnostics's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Cyduct Diagnostics's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Cyduct Diagnostics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Cyduct Diagnostics's FCF Margin % or its related term are showing as below:


CYDX's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.03
* Ranked among companies with meaningful FCF Margin % only.

Cyduct Diagnostics FCF Margin % Related Terms

Cyduct Diagnostics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics FCF Margin % Chart

Cyduct Diagnostics Annual Data
Trend
FCF Margin %

Cyduct Diagnostics Quarterly Data
FCF Margin %

CYDX vs SECI, QTXB, ASNB: FCF Margin % Comparison

For the Medical Devices subindustry, Cyduct Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyduct Diagnostics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cyduct Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cyduct Diagnostics's FCF Margin % falls into.


Cyduct Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cyduct Diagnostics's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Cyduct Diagnostics's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Cyduct Diagnostics (CYDX) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cyduct Diagnostics and its competitors.
Is Cyduct Diagnostics' FCF Margin % too high?
Cyduct Diagnostics' current FCF Margin % is 0.00%.
How does Cyduct Diagnostics' FCF Margin % compare to SECI and QTXB?
Cyduct Diagnostics' FCF Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cyduct Diagnostics and its competitors. Cyduct Diagnostics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyduct Diagnostics stock overvalued right now?
Cyduct Diagnostics (CYDX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cyduct Diagnostics (CYDX), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.